<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/03/31/2020.03.30.015461.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.03.30.015461v1"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein"/>
  <meta name="DC.Identifier" content="10.1101/2020.03.30.015461"/>
  <meta name="DC.Date" content="2020-03-31"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission."/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target."/>
  <meta name="DC.Contributor" content="Chek Meng Poh"/>
  <meta name="DC.Contributor" content="Guillaume Carissimo"/>
  <meta name="DC.Contributor" content="Bei Wang"/>
  <meta name="DC.Contributor" content="Siti Naqiah Amrun"/>
  <meta name="DC.Contributor" content="Cheryl Yi-Pin Lee"/>
  <meta name="DC.Contributor" content="Rhonda Sin-Ling Chee"/>
  <meta name="DC.Contributor" content="Nicholas Kim-Wah Yeo"/>
  <meta name="DC.Contributor" content="Wen-Hsin Lee"/>
  <meta name="DC.Contributor" content="Yee-Sin Leo"/>
  <meta name="DC.Contributor" content="Mark I-Cheng Chen"/>
  <meta name="DC.Contributor" content="Seow-Yen Tan"/>
  <meta name="DC.Contributor" content="Louis Yi Ann Chai"/>
  <meta name="DC.Contributor" content="Shirin Kalimuddin"/>
  <meta name="DC.Contributor" content="Siew-Yee Thien"/>
  <meta name="DC.Contributor" content="Barnaby Edward Young"/>
  <meta name="DC.Contributor" content="David C. Lye"/>
  <meta name="DC.Contributor" content="Cheng-I Wang"/>
  <meta name="DC.Contributor" content="Laurent Renia"/>
  <meta name="DC.Contributor" content="Lisa F.P. Ng"/>
  <meta name="article:published_time" content="2020-03-31"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.03.30.015461v1"/>
  <meta name="citation_id" content="2020.03.30.015461v1"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.03.30.015461v1"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.30.015461v1.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.30.015461v1.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.03.30.015461"/>
  <meta name="citation_num_pages" content="11"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.03.30.015461"/>
  <meta name="citation_author" content="Chek Meng Poh"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Guillaume Carissimo"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-9703-9096"/>
  <meta name="citation_author" content="Bei Wang"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Siti Naqiah Amrun"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Cheryl Yi-Pin Lee"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Rhonda Sin-Ling Chee"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Nicholas Kim-Wah Yeo"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Wen-Hsin Lee"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Yee-Sin Leo"/>
  <meta name="citation_author_institution" content="National Centre for Infectious Diseases"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Tan Tock Seng Hospital"/>
  <meta name="citation_author_institution" content="Lee Kong Chian School of Medicine, Nanyang Technological University"/>
  <meta name="citation_author_institution" content="Yong Loo Lin School of Medicine, National University of Singapore and National University Health System"/>
  <meta name="citation_author" content="Mark I-Cheng Chen"/>
  <meta name="citation_author_institution" content="National Centre for Infectious Diseases"/>
  <meta name="citation_author_institution" content="Saw Swee Hock School of Public Health, National University of Singapore and National University Health System"/>
  <meta name="citation_author" content="Seow-Yen Tan"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Changi General Hospital"/>
  <meta name="citation_author" content="Louis Yi Ann Chai"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Tan Tock Seng Hospital"/>
  <meta name="citation_author_institution" content="Department of Medicine, National University Hospital"/>
  <meta name="citation_author" content="Shirin Kalimuddin"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Singapore General Hospital"/>
  <meta name="citation_author_institution" content="Emerging Infectious Disease Program, Duke-NUS Medical School"/>
  <meta name="citation_author" content="Siew-Yee Thien"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Singapore General Hospital"/>
  <meta name="citation_author" content="Barnaby Edward Young"/>
  <meta name="citation_author_institution" content="National Centre for Infectious Diseases"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Tan Tock Seng Hospital"/>
  <meta name="citation_author_institution" content="Lee Kong Chian School of Medicine, Nanyang Technological University"/>
  <meta name="citation_author" content="David C. Lye"/>
  <meta name="citation_author_institution" content="National Centre for Infectious Diseases"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases, Tan Tock Seng Hospital"/>
  <meta name="citation_author_institution" content="Lee Kong Chian School of Medicine, Nanyang Technological University"/>
  <meta name="citation_author_institution" content="Yong Loo Lin School of Medicine, National University of Singapore and National University Health System"/>
  <meta name="citation_author" content="Cheng-I Wang"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Laurent Renia"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author" content="Lisa F.P. Ng"/>
  <meta name="citation_author_institution" content="Singapore Immunology Network, Agency of Science, Technology and Research"/>
  <meta name="citation_author_institution" content="Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore"/>
  <meta name="citation_author_institution" content="Institute of Infection and Global Health, University of Liverpool"/>
  <meta name="citation_author_email" content="lisa_ng@immunol.a-star.edu.sg"/>
  <meta name="citation_reference" content="Cohen J, Normile D. New SARS-like virus in China triggers alarm. Science. 2020;367(6475):234–5. doi: 10.1126/science.367.6475.234. PubMed PMID: 31949058."/>
  <meta name="citation_reference" content="Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. doi: 10.1126/science.abb2507. PubMed PMID: 32075877."/>
  <meta name="citation_reference" content="Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020. doi: 10.1016/j.cell.2020.02.058. PubMed PMID: 32155444."/>
  <meta name="citation_reference" content="Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020. doi: 10.1038/s41564-020-0688-y. PubMed PMID: 32094589."/>
  <meta name="citation_reference" content="Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020. doi: 10.1016/j.cell.2020.02.052. PubMed PMID: 32142651."/>
  <meta name="citation_reference" content="Lv H, Wu NC, Tsang OT-Y, Yuan M, Perera RAPM, Leung WS, et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. bioRxiv. 2020:2020.03.15.993097. doi: 10.1101/2020.03.15.993097."/>
  <meta name="citation_reference" content="Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020. doi: 10.1016/j.chom.2020.03.002. PubMed PMID: 32183941."/>
  <meta name="citation_reference" content="Zheng M, Song L. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cell Mol Immunol. 2020. doi: 10.1038/s41423-020-0385-z. PubMed PMID: 32132669."/>
  <meta name="citation_reference" content="Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020;12(3). doi: 10.3390/v12030254. PubMed PMID: 32106567."/>
  <meta name="citation_reference" content="Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol. 2009;83(15):7411–21. doi: 10.1128/JVI.00079-09. PubMed PMID: 19439480; PubMed Central PMCID: PMCPMC2708636."/>
  <meta name="citation_reference" content="Alsaadi EAJ, Neuman BW, Jones IM. A Fusion Peptide in the Spike Protein of MERS Coronavirus. Viruses. 2019;11(9). doi: 10.3390/v11090825. PubMed PMID: 31491938; PubMed Central PMCID: PMCPMC6784214."/>
  <meta name="citation_reference" content="Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng CK, et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019;5(4):eaav4580. doi: 10.1126/sciadv.aav4580. PubMed PMID: 30989115; PubMed Central PMCID: PMCPMC6457931."/>
  <meta name="citation_reference" content="Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020;9(1):382–5. doi: 10.1080/22221751.2020.1729069. PubMed PMID: 32065055; PubMed Central PMCID: PMCPMC7048180."/>
  <meta name="citation_reference" content="Zhao WM, Song SH, Chen ML, Zou D, Ma LN, Ma YK, et al. The 2019 novel coronavirus resource. Yi Chuan. 2020;42(2):212–21. doi: 10.16288/j.yczz.20-030. PubMed PMID: 32102777."/>
  <meta name="twitter:title" content="Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target."/>
  <meta name="og-title" property="og:title" content="Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.03.30.015461v1"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-03-31"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1219034 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results"> 
  <div class="article fulltext-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2 class="">Abstract</h2>
    <p id="p-3">The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target.</p>
   </div>
   <div class="section" id="sec-1">
    <h2 class="">Main</h2>
    <p id="p-4">In December 2019, a cluster of pneumonia cases of unknown etiology was reported in the city of Wuhan in the province of Hubei. The previously unidentified pathogen, which induces symptoms resembling an infection by the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), was later identified as a novel coronavirus, SARS-CoV-2 [
     <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>]. Within a span of four months, there are more than 750,000 laboratory-confirmed cases of human Coronavirus Disease 2019 (COVID-19), with over 35,000 deaths across 199 countries and territories (For up to date information consult 
     <a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/</a>). After being declared a pandemic by World Health Organization (WHO) on 11
     <sup>th</sup> March 2020, there is a compelling need to understand and develop effective therapeutic interventions against SARS-CoV-2.
    </p>
    <p id="p-5">SARS-CoV-2 uses the spike (S) glycoprotein to bind to the angiotensin-converting enzyme 2 (ACE2) receptor with a better affinity than SARS-CoV S glycoprotein for entry [
     <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>]. Thus, blocking the binding to ACE2, or blocking host protease cleavage to release the fusion peptide is an efficient strategy to prevent coronavirus entry [
     <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>-
     <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>]. To date, one study has assessed the immunogenicity of structural domains of recombinant SARS-CoV-2 S protein [
     <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>]. At the time of writing, findings on SARS-CoV-2 linear epitopes remain limited to bioinformatics prediction of human B and T-cell epitopes using SARS-CoV as a model [
     <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>-
     <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>]. Five regions on the S glycoprotein of SARS-CoV (residues 274-306, 510-586, 587-628, 784-803 and 870-893) were predicted to be associated with a robust immune response [
     <a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a>], while other studies reported candidate epitopes [
     <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>, 
     <a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>] that require validation with human patient samples.
    </p>
    <p id="p-6">In this brief communication, we report the antibody profiles of COVID-19 patients, and the identification of two immunodominant linear B-cell epitopes on the S glycoprotein of SARS-CoV-2 that are crucial in controlling infection. A total of 25 convalescence serum samples collected during the current COVID-19 outbreak in Singapore were screened at 1:1000 dilution for neutralizing antibodies against a pseudotyped lentivirus expressing SARS-CoV-2 S glycoprotein tagged with a luciferase reporter (
     <a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1a</a>). Of the 25 patients tested, six patients (2, 4, 6, 7, 11, 20) with sufficient amount of serum samples that displayed a good neutralizing activity were selected for further functional characterization. Sera from all patients showed similar IC
     <sub>50</sub>, ranging from a titre of 694 to 836, except patient 20, who showed the strongest neutralizing activity with an IC
     <sub>50</sub> of 1603 (
     <a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1b</a>).
    </p>
    <div id="F1" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F1.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="COVID-19 patients elicit neutralizing and specific antibody response against SARS-CoV-2. (a-b) Sera of COVID-19 patients (n=25) were mixed with pseudotyped lentiviruses expressing SARS-CoV-2 spike (S) glycoprotein protein, prior to incubation with CHO-ACE2 cells for 48 h. Infection levels were determined by luciferase assay, and percentage of infected cells were analyzed. Healthy control and recovered SARS patients (n=5) were also conducted in parallel. (a) Percentage of virus neutralization at 1:1000 sera dilution. IC50 titer is the reciprocal of sera dilution at which half-maximal neutralization was observed (dotted lines). (b) Dose-response neutralization kinetics from sera (1:50 to 1:12800 dilutions) of selected COVID-19 patients (n=6). Dotted lines indicate 50% neutralization or percentage neutralization of SARS patients (n=5) at 1:100 sera dilution. (c) Preliminary mapping of linear B cell epitopes within SARS-CoV-2 and SARS-CoV S protein. Sera of COVID-19 (n=6) and SARS patients (n=5) at 1:1000 dilution were subjected to peptide-based ELISA for IgG using peptide pools of the S protein of SARS-CoV-2 (pools S1-31) and SARS-CoV (pools S32-62) in duplicates. Sera of pooled healthy donors (n=13) were carried out in parallel. Data were normalized against healthy controls and the subtracted OD values are presented in a heat-map. Blue and pink indicate low and high OD values, respectively. (d-e) Determination of SARS-CoV-2 specific and pan-CoV linear B cell epitopes on S protein. (d) Sera of COVID-19 patients (n=6) were subjected to peptide-based ELISA for IgG detection using individual peptides of SARS-CoV-2 S peptide pools 14 and 21. The z-score values of patient were calculated using the formula [value [[#x2013]] average (OD value of patient) / standard deviation (OD value of patient)]. Data shown are from two independent experiments and presented as mean. (e) Peptide binding response of COVID-19 patients on SARS-CoV-2 peptides S14P5 and S21P2, and the corresponding regions on SARS-CoV peptides S45P3 and S51P5, respectively. Statistical analysis was carried out with paired parametric two-tailed t-test (*p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1431854247" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;COVID-19 patients elicit neutralizing and specific antibody response against SARS-CoV-2.&lt;;/span&gt;; &lt;;strong&gt;;(a-b)&lt;;/strong&gt;; Sera of COVID-19 patients (n=25) were mixed with pseudotyped lentiviruses expressing SARS-CoV-2 spike (S) glycoprotein protein, prior to incubation with CHO-ACE2 cells for 48 h. Infection levels were determined by luciferase assay, and percentage of infected cells were analyzed. Healthy control and recovered SARS patients (n=5) were also conducted in parallel. &lt;;strong&gt;;(a)&lt;;/strong&gt;; Percentage of virus neutralization at 1:1000 sera dilution. IC&lt;;sub&gt;;50&lt;;/sub&gt;; titer is the reciprocal of sera dilution at which half-maximal neutralization was observed (dotted lines). &lt;;strong&gt;;(b)&lt;;/strong&gt;; Dose-response neutralization kinetics from sera (1:50 to 1:12800 dilutions) of selected COVID-19 patients (n=6). Dotted lines indicate 50% neutralization or percentage neutralization of SARS patients (n=5) at 1:100 sera dilution. &lt;;strong&gt;;(c)&lt;;/strong&gt;; Preliminary mapping of linear B cell epitopes within SARS-CoV-2 and SARS-CoV S protein. Sera of COVID-19 (n=6) and SARS patients (n=5) at 1:1000 dilution were subjected to peptide-based ELISA for IgG using peptide pools of the S protein of SARS-CoV-2 (pools S1-31) and SARS-CoV (pools S32-62) in duplicates. Sera of pooled healthy donors (n=13) were carried out in parallel. Data were normalized against healthy controls and the subtracted OD values are presented in a heat-map. Blue and pink indicate low and high OD values, respectively. &lt;;strong&gt;;(d-e)&lt;;/strong&gt;; Determination of SARS-CoV-2 specific and pan-CoV linear B cell epitopes on S protein. &lt;;strong&gt;;(d)&lt;;/strong&gt;; Sera of COVID-19 patients (n=6) were subjected to peptide-based ELISA for IgG detection using individual peptides of SARS-CoV-2 S peptide pools 14 and 21. The z-score values of patient were calculated using the formula [value [[#x2013]] average (OD value of patient) / standard deviation (OD value of patient)]. Data shown are from two independent experiments and presented as mean. &lt;;strong&gt;;(e)&lt;;/strong&gt;; Peptide binding response of COVID-19 patients on SARS-CoV-2 peptides S14P5 and S21P2, and the corresponding regions on SARS-CoV peptides S45P3 and S51P5, respectively. Statistical analysis was carried out with paired parametric two-tailed t-test (*&lt;;em&gt;;p&lt;;/em&gt;;&lt;;0.05).&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F1.medium.gif" width="440" height="364"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F1.medium.gif" width="440" height="364"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 1.</span>
      <span class="caption-title">COVID-19 patients elicit neutralizing and specific antibody response against SARS-CoV-2.</span>
      <p id="p-7" class="first-child">
       <strong>(a-b)</strong> Sera of COVID-19 patients (n=25) were mixed with pseudotyped lentiviruses expressing SARS-CoV-2 spike (S) glycoprotein protein, prior to incubation with CHO-ACE2 cells for 48 h. Infection levels were determined by luciferase assay, and percentage of infected cells were analyzed. Healthy control and recovered SARS patients (n=5) were also conducted in parallel. 
       <strong>(a)</strong> Percentage of virus neutralization at 1:1000 sera dilution. IC
       <sub>50</sub> titer is the reciprocal of sera dilution at which half-maximal neutralization was observed (dotted lines). 
       <strong>(b)</strong> Dose-response neutralization kinetics from sera (1:50 to 1:12800 dilutions) of selected COVID-19 patients (n=6). Dotted lines indicate 50% neutralization or percentage neutralization of SARS patients (n=5) at 1:100 sera dilution. 
       <strong>(c)</strong> Preliminary mapping of linear B cell epitopes within SARS-CoV-2 and SARS-CoV S protein. Sera of COVID-19 (n=6) and SARS patients (n=5) at 1:1000 dilution were subjected to peptide-based ELISA for IgG using peptide pools of the S protein of SARS-CoV-2 (pools S1-31) and SARS-CoV (pools S32-62) in duplicates. Sera of pooled healthy donors (n=13) were carried out in parallel. Data were normalized against healthy controls and the subtracted OD values are presented in a heat-map. Blue and pink indicate low and high OD values, respectively. 
       <strong>(d-e)</strong> Determination of SARS-CoV-2 specific and pan-CoV linear B cell epitopes on S protein. 
       <strong>(d)</strong> Sera of COVID-19 patients (n=6) were subjected to peptide-based ELISA for IgG detection using individual peptides of SARS-CoV-2 S peptide pools 14 and 21. The z-score values of patient were calculated using the formula [value – average (OD value of patient) / standard deviation (OD value of patient)]. Data shown are from two independent experiments and presented as mean. 
       <strong>(e)</strong> Peptide binding response of COVID-19 patients on SARS-CoV-2 peptides S14P5 and S21P2, and the corresponding regions on SARS-CoV peptides S45P3 and S51P5, respectively. Statistical analysis was carried out with paired parametric two-tailed t-test (*
       <em>p</em>&lt;;0.05).
      </p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-8">Next, we assessed the antigenic targets of these sera using a linear B-cell peptide library spanning the entire S protein of either SARS-CoV or SARS-CoV-2 with pools of five overlapping peptides (
     <a id="xref-fig-1-3" class="xref-fig" href="#F1">Figure 1c</a>, Supplementary Figure 1b). Interestingly, two distinct peptide pools from SARS-CoV-2 S library, pools S14 and S21, were strongly detected by sera from COVID-19 patients, and not by recovered SARS patients (17 years post disease recovery) (
     <a id="xref-fig-1-4" class="xref-fig" href="#F1">Figure 1c</a>, Supplementary Figure 1b). Sera from recalled SARS patients could neutralize SARS-CoV, but not the SARS-CoV-2 pseudotyped lentiviruses (Supplementary Figure 1c). Moreover, COVID-19 patients sera could strongly detect SARS-CoV S library pool S51, which partially overlaps with SARS-CoV-2 pool S21 (
     <a id="xref-fig-1-5" class="xref-fig" href="#F1">Figure 1c</a>, Supplementary Figure 1b). This region encompasses the fusion peptide, which is highly conserved among coronaviruses [
     <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>, 
     <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>], suggesting a potential pan-coronavirus epitope at this location. Interestingly, targeting this region was also demonstrated to neutralize infection with a pan-coronavirus fusion inhibitor peptide [
     <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>]. Surprisingly, no linear epitope was identified in the receptor binding domain (RBD) which suggest that antibodies targeting that region are mostly conformational epitopes. Further assessment of individual peptides within pools S14 and S21 narrowed down the specific region of interest to peptides S14P5 and S21P2, respectively (
     <a id="xref-fig-1-6" class="xref-fig" href="#F1">Figure 1d</a>). Recognition of these regions was stronger for the peptides of SARS-CoV-2 than SARS-CoV (
     <a id="xref-fig-1-7" class="xref-fig" href="#F1">Figure 1e</a>). Together, these findings suggest that these linear B-cell epitopes are dominant antigenic regions, which corroborated previous bioinformatics predictions [
     <a id="xref-ref-7-3" class="xref-bibr" href="#ref-7">7</a>].
    </p>
    <p id="p-9">Using a recently published structure of SARS-CoV-2 S protein in prefusion conformation [
     <a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>], peptide S14P5 is localized in proximity to the RBD (
     <a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2a</a>). As such, it is plausible that antibodies binding to this region may sterically hinder binding to ACE2 receptor, thereby abolishing virus infection [
     <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>]. Another possibility could be an allosteric effect on ACE2 binding. Similarly, peptide S21P2 contains a part of the fusion peptide sequence, which may potentially affect virus fusion (
     <a id="xref-fig-2-2" class="xref-fig" href="#F2">Figure 2b</a>). In order to assess the importance of these regions in controlling SARS-CoV-2 infection, antibody depletion assays were performed against S14P5 and S21P2 (
     <a id="xref-fig-2-3" class="xref-fig" href="#F2">Figure 2c</a>). Depletion efficiency and specificity was validated by ELISA, showing that only antibodies against the respective peptides were depleted but not other unrelated antibodies (
     <a id="xref-fig-2-4" class="xref-fig" href="#F2">Figure 2d</a>). Interestingly, sera that were depleted for antibodies targeting either peptides S14P5, S21P2, or S14P5+S21P2 led to a significantly reduced ability to neutralize SARS-CoV-2 pseudovirus infection, as compared to the non-depleted sera controls (
     <a id="xref-fig-2-5" class="xref-fig" href="#F2">Figure 2e</a>).
    </p>
    <div id="F2" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F2.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Antibodies against S14P5 and S21P2 linear B-cell epitopes neutralize SARS-CoV-2. (a-b) Localization and sequences of (a) SAR-CoV-2 specific S14P5 and (b) pan-CoV S21P2 epitopes on spike (S) protein (PDB: 6VSB) are shown. Each S monomer is denoted as either pink, blue or orange. (c-e) Pooled sera of COVID-19 patients (n=6) were added to plates coated with the corresponding peptides to deplete specific antibodies. (c) Non-depleted and peptide-specific antibody-depleted sera were then subjected to peptide-based ELISA of the peptide (d) or were cross-assayed. Data of depleted sera (white) were normalized to percentages of the non-depleted sera (black). Signal from pooled healthy donor sera were displayed as black dotted lines and data are shown as mean [[#xB1]] SD. (e) Non-depleted and peptide-specific antibody-depleted pooled sera were then mixed with SARS-CoV-2 pseudovirus before incubating with CHO-ACE2 cells for 48 h. The percentage of neutralization against pseudovirus infection, relative to the non-depleted sera, are shown. Data are presented as mean [[#xB1]] SD, and signal from pooled healthy donor sera were displayed as black dotted lines. Statistical analysis was carried out with one-sample t test (*p" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1431854247" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;Antibodies against S14P5 and S21P2 linear B-cell epitopes neutralize SARS-CoV-2.&lt;;/span&gt;; &lt;;strong&gt;;(a-b)&lt;;/strong&gt;; Localization and sequences of &lt;;strong&gt;;(a)&lt;;/strong&gt;; SAR-CoV-2 specific S14P5 and &lt;;strong&gt;;(b)&lt;;/strong&gt;; pan-CoV S21P2 epitopes on spike (S) protein (PDB: 6VSB) are shown. Each S monomer is denoted as either pink, blue or orange. &lt;;strong&gt;;(c-e)&lt;;/strong&gt;; Pooled sera of COVID-19 patients (n=6) were added to plates coated with the corresponding peptides to deplete specific antibodies. &lt;;strong&gt;;(c)&lt;;/strong&gt;; Non-depleted and peptide-specific antibody-depleted sera were then subjected to peptide-based ELISA of the peptide &lt;;strong&gt;;(d)&lt;;/strong&gt;; or were cross-assayed. Data of depleted sera (white) were normalized to percentages of the non-depleted sera (black). Signal from pooled healthy donor sera were displayed as black dotted lines and data are shown as mean [[#xB1]] SD. &lt;;strong&gt;;(e)&lt;;/strong&gt;; Non-depleted and peptide-specific antibody-depleted pooled sera were then mixed with SARS-CoV-2 pseudovirus before incubating with CHO-ACE2 cells for 48 h. The percentage of neutralization against pseudovirus infection, relative to the non-depleted sera, are shown. Data are presented as mean [[#xB1]] SD, and signal from pooled healthy donor sera were displayed as black dotted lines. Statistical analysis was carried out with one-sample t test (*&lt;;em&gt;;p&lt;;/em&gt;;&lt;;0.05, **&lt;;em&gt;;p&lt;;/em&gt;;&lt;;0.01).&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F2.medium.gif" width="440" height="401"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F2.medium.gif" width="440" height="401"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.30.015461/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 2.</span>
      <span class="caption-title">Antibodies against S14P5 and S21P2 linear B-cell epitopes neutralize SARS-CoV-2.</span>
      <p id="p-10" class="first-child">
       <strong>(a-b)</strong> Localization and sequences of 
       <strong>(a)</strong> SAR-CoV-2 specific S14P5 and 
       <strong>(b)</strong> pan-CoV S21P2 epitopes on spike (S) protein (PDB: 6VSB) are shown. Each S monomer is denoted as either pink, blue or orange. 
       <strong>(c-e)</strong> Pooled sera of COVID-19 patients (n=6) were added to plates coated with the corresponding peptides to deplete specific antibodies. 
       <strong>(c)</strong> Non-depleted and peptide-specific antibody-depleted sera were then subjected to peptide-based ELISA of the peptide 
       <strong>(d)</strong> or were cross-assayed. Data of depleted sera (white) were normalized to percentages of the non-depleted sera (black). Signal from pooled healthy donor sera were displayed as black dotted lines and data are shown as mean ± SD. 
       <strong>(e)</strong> Non-depleted and peptide-specific antibody-depleted pooled sera were then mixed with SARS-CoV-2 pseudovirus before incubating with CHO-ACE2 cells for 48 h. The percentage of neutralization against pseudovirus infection, relative to the non-depleted sera, are shown. Data are presented as mean ± SD, and signal from pooled healthy donor sera were displayed as black dotted lines. Statistical analysis was carried out with one-sample t test (*
       <em>p</em>&lt;;0.05, **
       <em>p</em>&lt;;0.01).
      </p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-11">Our results demonstrate that the two B-cell linear epitopes identified in this study are immunodominant. Depletion assays functionally validated that antibodies targeting S14P5 and S21P2 peptides possess significant neutralizing roles against SARS-CoV-2 pseudotyped lentiviruses. Importantly, we also assessed the potential presence of mutations in the peptide regions and found a low rate of mutations for S14P5 and S21P2 with low to moderate impact on the viral sequence (2 and 24 mutations out of 2596 viral genome sequences respectively, supplementary table 3) [
     <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>]. These results are essential to guide the design and evaluation of efficient and specific serological assays, as well as help prioritize vaccine target designs during this unprecedented crisis.
    </p>
   </div>
   <div class="section" id="sec-3">
    <h2 class="">Author contributions</h2>
    <p id="p-13">CMP, GC, SNA, CYPL conceptualized, designed, acquired, analyzed, interpreted the data and wrote the manuscript. BW acquired, analyzed, interpreted the data and wrote the manuscript. RSLC, WHL and NKWY acquired and analyzed the data. YSL, MICC, SYT, LC, SK, SYT, BEY, and DCL designed and supervised sample collection. CIW, LR, LFPN conceptualized, designed, analyzed and wrote the manuscript. All authors revised and approved the final version of the manuscript.</p>
   </div>
   <div class="section" id="sec-4">
    <h2 class="">Competing interests</h2>
    <p id="p-14">The authors declare no conflict of interest.</p>
   </div>
   <div class="section" id="sec-5">
    <h2 class="">Funding</h2>
    <p id="p-15">This work was supported by core research grants provided to Singapore Immunology Network by the Biomedical Research Council (BMRC), and by the A*ccelerate GAP-funded project (ACCL/19-GAP064-R20H-H). Subject recruitment and sample collection was funded by the National Medical Research Council (NMRC) COVID-19 Research fund (COVID19RF-001).</p>
   </div>
   <div class="section ack" id="ack-1">
    <h2 class="">Acknowledgements</h2>
    <p id="p-12">Authors would like to thank Professor Yee-Joo Tan (Department of Microbiology, NUS) who kindly provided CHO-ACE2 cells and pXJ3’-S plasmid, and Assoc. Prof. Brendon Hanson (Defence Science Organization National Laboratories) who kindly provided pTT5LnX-CoV-SP plasmid. We would also like to thank the study participants who donated their blood samples to this project, and the healthcare workers who are caring for patients with COVID-19.</p>
   </div>
   <div class="section ref-list" id="ref-list-1">
    <h2 class="">References</h2>
    <ol class="cit-list ref-use-labels">
     <li>
      <span class="ref-label">1.</span>
      <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.1" data-doi="10.1126/science.367.6475.234">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Cohen</span>
          <span class="cit-name-given-names">J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Normile</span>
          <span class="cit-name-given-names">D.</span>
         </span>
         <span class="cit-article-title">New SARS-like virus in China triggers alarm</span>. 
         <abbr class="cit-jnl-abbrev">Science</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">367</span>(
         <span class="cit-issue">6475</span>):
         <span class="cit-fpage">234</span>–
         <span class="cit-lpage">5</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1126/science.367.6475.234</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">31949058</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DCohen%26rft.auinit1%253DJ.%26rft.volume%253D367%26rft.issue%253D6475%26rft.spage%253D234%26rft.epage%253D235%26rft.atitle%253DNew%2BSARS-like%2Bvirus%2Bin%2BChina%2Btriggers%2Balarm%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.367.6475.234%26rft_id%253Dinfo%253Apmid%252F31949058%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEyOiIzNjcvNjQ3NS8yMzQiO3M6NDoiYXRvbSI7czo0ODoiL2Jpb3J4aXYvZWFybHkvMjAyMC8wMy8zMS8yMDIwLjAzLjMwLjAxNTQ2MS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">2.</span>
      <a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.2" data-doi="10.1126/science.abb2507">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Wrapp</span>
          <span class="cit-name-given-names">D</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wang</span>
          <span class="cit-name-given-names">N</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Corbett</span>
          <span class="cit-name-given-names">KS</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Goldsmith</span>
          <span class="cit-name-given-names">JA</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hsieh</span>
          <span class="cit-name-given-names">CL</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Abiona</span>
          <span class="cit-name-given-names">O</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span>. 
         <abbr class="cit-jnl-abbrev">Science</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">367</span>(
         <span class="cit-issue">6483</span>):
         <span class="cit-fpage">1260</span>–
         <span class="cit-lpage">3</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1126/science.abb2507</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32075877</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DScience%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.abb2507%26rft_id%253Dinfo%253Apmid%252F32075877%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIzNjcvNjQ4My8xMjYwIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4zMC4wMTU0NjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">3.</span>
      <a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.3" data-doi="10.1016/j.cell.2020.02.058">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Walls</span>
          <span class="cit-name-given-names">AC</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Park</span>
          <span class="cit-name-given-names">YJ</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tortorici</span>
          <span class="cit-name-given-names">MA</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wall</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">McGuire</span>
          <span class="cit-name-given-names">AT</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Veesler</span>
          <span class="cit-name-given-names">D.</span>
         </span>
         <span class="cit-article-title">Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</span>. 
         <abbr class="cit-jnl-abbrev">Cell</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.cell.2020.02.058</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32155444</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DCell%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2020.02.058%26rft_id%253Dinfo%253Apmid%252F32155444%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.cell.2020.02.058&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32155444&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">4.</span>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.30.015461v1.4" data-doi="10.1038/s41564-020-0688-y">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Letko</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Marzi</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Munster</span>
          <span class="cit-name-given-names">V.</span>
         </span>
         <span class="cit-article-title">Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses</span>. 
         <abbr class="cit-jnl-abbrev">Nat Microbiol</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/s41564-020-0688-y</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32094589</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNat%2BMicrobiol%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41564-020-0688-y%26rft_id%253Dinfo%253Apmid%252F32094589%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/s41564-020-0688-y&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32094589&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">5.</span>
      <a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.5" data-doi="10.1016/j.cell.2020.02.052">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Hoffmann</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Kleine-Weber</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Schroeder</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Kruger</span>
          <span class="cit-name-given-names">N</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Herrler</span>
          <span class="cit-name-given-names">T</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Erichsen</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</span>. 
         <abbr class="cit-jnl-abbrev">Cell</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.cell.2020.02.052</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32142651</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DCell%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2020.02.052%26rft_id%253Dinfo%253Apmid%252F32142651%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.cell.2020.02.052&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32142651&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">6.</span>
      <a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.6" data-doi="10.1101/2020.03.15.993097">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Lv</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wu</span>
          <span class="cit-name-given-names">NC</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tsang</span>
          <span class="cit-name-given-names">OT-Y</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Yuan</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Perera</span>
          <span class="cit-name-given-names">RAPM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Leung</span>
          <span class="cit-name-given-names">WS</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections</span>. 
         <abbr class="cit-jnl-abbrev">bioRxiv</abbr>. 
         <span class="cit-pub-date">2020</span>:2020.03.15.993097.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1101/2020.03.15.993097</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DbioRxiv%26rft_id%253Dinfo%253Adoi%252F10.1101%252F2020.03.15.993097%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYmlvcnhpdiI7czo1OiJyZXNpZCI7czoxOToiMjAyMC4wMy4xNS45OTMwOTd2MSI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzMxLzIwMjAuMDMuMzAuMDE1NDYxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">7.</span>
      <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.7" data-doi="10.1016/j.chom.2020.03.002">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Grifoni</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Sidney</span>
          <span class="cit-name-given-names">J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zhang</span>
          <span class="cit-name-given-names">Y</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Scheuermann</span>
          <span class="cit-name-given-names">RH</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Peters</span>
          <span class="cit-name-given-names">B</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Sette</span>
          <span class="cit-name-given-names">A.</span>
         </span>
         <span class="cit-article-title">A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2</span>. 
         <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.chom.2020.03.002</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32183941</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2020.03.002%26rft_id%253Dinfo%253Apmid%252F32183941%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.chom.2020.03.002&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32183941&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">8.</span>
      <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.8" data-doi="10.1038/s41423-020-0385-z">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zheng</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Song</span>
          <span class="cit-name-given-names">L.</span>
         </span>
         <span class="cit-article-title">Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV</span>. 
         <abbr class="cit-jnl-abbrev">Cell Mol Immunol</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/s41423-020-0385-z</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32132669</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DCell%2BMol%2BImmunol%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41423-020-0385-z%26rft_id%253Dinfo%253Apmid%252F32132669%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/s41423-020-0385-z&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32132669&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">9.</span>
      <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.9" data-doi="10.3390/v12030254">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Ahmed</span>
          <span class="cit-name-given-names">SF</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Quadeer</span>
          <span class="cit-name-given-names">AA</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">McKay</span>
          <span class="cit-name-given-names">MR</span>
         </span>. 
         <span class="cit-article-title">Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies</span>. 
         <abbr class="cit-jnl-abbrev">Viruses</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">12</span>(
         <span class="cit-issue">3</span>).
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.3390/v12030254</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32106567</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DViruses%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv12030254%26rft_id%253Dinfo%253Apmid%252F32106567%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.3390/v12030254&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32106567&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">10.</span>
      <a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.10" data-doi="10.1128/JVI.00079-09">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Madu</span>
          <span class="cit-name-given-names">IG</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Roth</span>
          <span class="cit-name-given-names">SL</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Belouzard</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Whittaker</span>
          <span class="cit-name-given-names">GR</span>
         </span>. 
         <span class="cit-article-title">Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide</span>. 
         <abbr class="cit-jnl-abbrev">J Virol</abbr>. 
         <span class="cit-pub-date">2009</span>;
         <span class="cit-vol">83</span>(
         <span class="cit-issue">15</span>):
         <span class="cit-fpage">7411</span>–
         <span class="cit-lpage">21</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.00079-09</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">19439480</span>
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep">;</span> PubMed Central
         <span class="cit-pub-id-sep cit-pub-id-pmcid-sep"> </span>
         <span class="cit-pub-id-scheme">PMCID: </span>
         <span class="cit-pub-id cit-pub-id-pmcid">PMCPMC2708636</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00079-09%26rft_id%253Dinfo%253Apmid%252F19439480%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4My8xNS83NDExIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4zMC4wMTU0NjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">11.</span>
      <a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.11" data-doi="10.3390/v11090825">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Alsaadi</span>
          <span class="cit-name-given-names">EAJ</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Neuman</span>
          <span class="cit-name-given-names">BW</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Jones</span>
          <span class="cit-name-given-names">IM</span>
         </span>. 
         <span class="cit-article-title">A Fusion Peptide in the Spike Protein of MERS Coronavirus</span>. 
         <abbr class="cit-jnl-abbrev">Viruses</abbr>. 
         <span class="cit-pub-date">2019</span>;
         <span class="cit-vol">11</span>(
         <span class="cit-issue">9</span>).
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.3390/v11090825</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">31491938</span>
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep">;</span> PubMed Central
         <span class="cit-pub-id-sep cit-pub-id-pmcid-sep"> </span>
         <span class="cit-pub-id-scheme">PMCID: </span>
         <span class="cit-pub-id cit-pub-id-pmcid">PMCPMC6784214</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DViruses%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv11090825%26rft_id%253Dinfo%253Apmid%252F31491938%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.3390/v11090825&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=31491938&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">12.</span>
      <a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.12" data-doi="10.1126/sciadv.aav4580">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Xia</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Yan</span>
          <span class="cit-name-given-names">L</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Xu</span>
          <span class="cit-name-given-names">W</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Agrawal</span>
          <span class="cit-name-given-names">AS</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Algaissi</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tseng</span>
          <span class="cit-name-given-names">CK</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike</span>. 
         <abbr class="cit-jnl-abbrev">Sci Adv</abbr>. 
         <span class="cit-pub-date">2019</span>;
         <span class="cit-vol">5</span>(
         <span class="cit-issue">4</span>):
         <span class="cit-fpage">eaav4580</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1126/sciadv.aav4580</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">30989115</span>
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep">;</span> PubMed Central
         <span class="cit-pub-id-sep cit-pub-id-pmcid-sep"> </span>
         <span class="cit-pub-id-scheme">PMCID: </span>
         <span class="cit-pub-id cit-pub-id-pmcid">PMCPMC6457931</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DScience%2BAdvances%26rft.stitle%253DSci%2BAdv%26rft.aulast%253DXia%26rft.auinit1%253DS.%26rft.volume%253D5%26rft.issue%253D4%26rft.spage%253Deaav4580%26rft.epage%253Deaav4580%26rft.atitle%253DA%2Bpan-coronavirus%2Bfusion%2Binhibitor%2Btargeting%2Bthe%2BHR1%2Bdomain%2Bof%2Bhuman%2Bcoronavirus%2Bspike%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fsciadv.aav4580%26rft_id%253Dinfo%253Apmid%252F30989115%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo4OiJhZHZhbmNlcyI7czo1OiJyZXNpZCI7czoxMjoiNS80L2VhYXY0NTgwIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4zMC4wMTU0NjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">13.</span>
      <a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.13" data-doi="10.1080/22221751.2020.1729069">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Tian</span>
          <span class="cit-name-given-names">X</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Li</span>
          <span class="cit-name-given-names">C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Huang</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Xia</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Lu</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Shi</span>
          <span class="cit-name-given-names">Z</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody</span>. 
         <abbr class="cit-jnl-abbrev">Emerg Microbes Infect</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">9</span>(
         <span class="cit-issue">1</span>):
         <span class="cit-fpage">382</span>–
         <span class="cit-lpage">5</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.1080/22221751.2020.1729069</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32065055</span>
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep">;</span> PubMed Central
         <span class="cit-pub-id-sep cit-pub-id-pmcid-sep"> </span>
         <span class="cit-pub-id-scheme">PMCID: </span>
         <span class="cit-pub-id cit-pub-id-pmcid">PMCPMC7048180</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DEmerg%2BMicrobes%2BInfect%26rft.volume%253D9%26rft.spage%253D382%26rft_id%253Dinfo%253Adoi%252F10.1080%252F22221751.2020.1729069%26rft_id%253Dinfo%253Apmid%252F32065055%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1080/22221751.2020.1729069&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32065055&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">14.</span>
      <a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.30.015461v1.14" data-doi="10.16288/j.yczz.20-030">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zhao</span>
          <span class="cit-name-given-names">WM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Song</span>
          <span class="cit-name-given-names">SH</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Chen</span>
          <span class="cit-name-given-names">ML</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zou</span>
          <span class="cit-name-given-names">D</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Ma</span>
          <span class="cit-name-given-names">LN</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Ma</span>
          <span class="cit-name-given-names">YK</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">The 2019 novel coronavirus resource</span>. 
         <abbr class="cit-jnl-abbrev">Yi Chuan</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">42</span>(
         <span class="cit-issue">2</span>):
         <span class="cit-fpage">212</span>–
         <span class="cit-lpage">21</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi: </span>
         <span class="cit-pub-id cit-pub-id-doi">10.16288/j.yczz.20-030</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">.</span> PubMed
         <span class="cit-pub-id-sep cit-pub-id-pmid-sep"> </span>
         <span class="cit-pub-id-scheme">PMID: </span>
         <span class="cit-pub-id cit-pub-id-pmid">32102777</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DYi%2BChuan%26rft.volume%253D42%26rft.spage%253D212%26rft_id%253Dinfo%253Adoi%252F10.16288%252Fj.yczz.20-030%26rft_id%253Dinfo%253Apmid%252F32102777%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.16288/j.yczz.20-030&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=32102777&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.30.015461.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
    </ol>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
